These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 467625

  • 21. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F, Bataille B, Cartilier L.
    Int J Pharm; 2008 May 22; 356(1-2):52-60. PubMed ID: 18280069
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Studies on direct compression of tablets. IV. The effect of particle size on the mechanical strength of tablets.
    Alderborn G, Nyström C.
    Acta Pharm Suec; 1982 May 22; 19(5):381-90. PubMed ID: 7180505
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Effervescent aspartame tablets: influence of granulometry on the stress exerted at the level of compression].
    Joachim J, Kalantzis G, Delonca H, Abramovici B, Lheritier J, Molard F.
    J Pharm Belg; 1987 May 22; 42(1):17-28. PubMed ID: 3585684
    [No Abstract] [Full Text] [Related]

  • 28. Sucrose esters with various hydrophilic-lipophilic properties: novel controlled release agents for oral drug delivery matrix tablets prepared by direct compaction.
    Chansanroj K, Betz G.
    Acta Biomater; 2010 Aug 22; 6(8):3101-9. PubMed ID: 20132913
    [Abstract] [Full Text] [Related]

  • 29. [Effects of compression pressure, drug particle size, drug form and test medium on the release of active ingredients from matrix tablets of a silicon base].
    Moldenhauer H, Kala H, Erbe S.
    Pharmazie; 1975 Dec 22; 30(12):783-7. PubMed ID: 1219796
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The use of micronized cellulose disintegrants as insoluble swellable matrices for sustained-release tablets.
    Nakagami H, Nada M.
    Drug Des Deliv; 1991 Jul 22; 7(4):321-32. PubMed ID: 1930623
    [Abstract] [Full Text] [Related]

  • 34. A comparative study of modified starches in direct compression of a water soluble drug-chloroquine phosphate.
    Okafor IS, Ofoefule SI, Udeala OK.
    Boll Chim Farm; 2000 Jul 22; 139(6):252-5. PubMed ID: 11213430
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Naproxen-Eudragit microspheres: screening of process and formulation variables for the preparation of extended release tablets.
    Zaghloul AA, Faltinek J, Vaithiyalingam SR, Reddy IK, Khan MA.
    Pharmazie; 2001 Apr 22; 56(4):321-4. PubMed ID: 11338673
    [Abstract] [Full Text] [Related]

  • 37. Preparation and in-vitro in-vivo evaluation of sustained release matrix diclofenac sodium tablets using PVP-K90 and natural gums.
    Iqbal Z, Khan R, Nasir F, Khan JA, Rashid A, Khan A, Khan A.
    Pak J Pharm Sci; 2011 Oct 22; 24(4):435-43. PubMed ID: 21959802
    [Abstract] [Full Text] [Related]

  • 38. Sustained-release dosage form of nitrofurantoin. Part 2. In vivo urinary excretion in man.
    Ertan G, Karasulu E, Abou-Nada M, Tosun M, Ozer A.
    J Microencapsul; 1994 Oct 22; 11(2):137-40. PubMed ID: 8006760
    [Abstract] [Full Text] [Related]

  • 39. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A, Ozkan Y, Işimer A.
    Farmaco; 2005 Feb 22; 60(2):171-7. PubMed ID: 15752476
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.